Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Professor Thrasyvoulos Tzellos is Dermatologist at the Department of Dermatology, NLSH Bodø, Norway, and Associate Professor at Institute of Clinical Medicine, University of Tromsø, Norway.
Professor Tzellos received his medical degree from the Aristotle University of Thessaloniki, Greece, moving on to complete an MSc in Clinical Research and Epidemiology and a PhD from the same institution. He has also completed several postgraduate courses on educational techniques, epidemiology and clinical pharmacology in healthcare.
He has published over 100 peer-reviewed articles and his current research expertise lies in the field of evidence-based medicine, clinical trials, meta-analyses, case-control studies, cohort studies and large-scale epidemiological studies. He is actively involved in clinical research on hidradenitis suppurativa and is a founding member of the European Hidradenitis Suppurativa Foundation (EHSF).
Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care